- Home
- MIRA vs AQMS Comparison
MIRA vs AQMS Comparison
Compare MIRA & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- AQMS
- Stock Information
- Founded
- MIRA 2020
- AQMS 2014
- Country
- MIRA United States
- AQMS United States
- Employees
- MIRA N/A
- AQMS N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- MIRA Health Care
- AQMS Industrials
- Exchange
- MIRA Nasdaq
- AQMS Nasdaq
- Market Cap
- MIRA 19.5M
- AQMS 7.7M
- IPO Year
- MIRA 2023
- AQMS 2015
- Fundamental
- Price
- MIRA $1.20
- AQMS $0.51
- Analyst Decision
- MIRA Strong Buy
- AQMS Strong Buy
- Analyst Count
- MIRA 2
- AQMS 3
- Target Price
- MIRA $14.00
- AQMS $21.00
- AVG Volume (30 Days)
- MIRA 1.9M
- AQMS 538.8K
- Earning Date
- MIRA 08-12-2025
- AQMS 08-04-2025
- Dividend Yield
- MIRA N/A
- AQMS N/A
- EPS Growth
- MIRA N/A
- AQMS N/A
- EPS
- MIRA N/A
- AQMS N/A
- Revenue
- MIRA N/A
- AQMS N/A
- Revenue This Year
- MIRA N/A
- AQMS N/A
- Revenue Next Year
- MIRA N/A
- AQMS $550.00
- P/E Ratio
- MIRA N/A
- AQMS N/A
- Revenue Growth
- MIRA N/A
- AQMS N/A
- 52 Week Low
- MIRA $0.51
- AQMS $0.47
- 52 Week High
- MIRA $5.01
- AQMS $7.92
- Technical
- Relative Strength Index (RSI)
- MIRA 46.10
- AQMS 32.45
- Support Level
- MIRA $1.21
- AQMS $0.47
- Resistance Level
- MIRA $1.26
- AQMS $0.83
- Average True Range (ATR)
- MIRA 0.09
- AQMS 0.06
- MACD
- MIRA -0.01
- AQMS 0.00
- Stochastic Oscillator
- MIRA 29.63
- AQMS 18.86
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.